All content for The Business of Eye Innovation is the property of Medevise Consulting and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
The podcast that explores insight, trends and opinion in the business of European ophthalmology.
In our second episode of The Business of Eye Innovation, we lift the lid on the re-imagination of British ophthalmology stalwart, Rayner Intraocular Lenses, as Medevise Founder, Kris Morrill, speaks to the inspiring duo of CEO, Tim Clover and VP of Marketing, Chris Willis.
Discover how this 111-year-old former chain of retail opticians and quiet pioneer of the IOL has transitioned into a high-tech medtech company and a partner of choice for innovators, surgeons, and academics. Plus learn Tim Clover’s take on the foundations for success, highlights of the company’s journey so far and what to expect in the next five years.
Chris Willis discusses his remit of raising Rayner’s share of voice of the reimagined Rayner and discloses some of the work and strategy behind the Plus 1 EMV campaign – which is putting Rayner right at the heart of industry conversation on monovision.
Find out more about RaynerConnect with Tim Clover, Chris Willis and Kris Morrill on LinkedIn
The Business of Eye Innovation
The podcast that explores insight, trends and opinion in the business of European ophthalmology.
